OliX Pharmaceuticals is a company that provides Medicine, Subretinal fibrosis, Rod-cone dystrophy and more. OliX Pharmaceuticals is headquartered in South Korea Ch'ungch'ong-namdo. OliX Pharmaceuticals was founded in 2010. and was founded by Dong-ki Lee. OliX Pharmaceuticals has a total of 111 patents and 1 literature
OliX is a clinical stage biotechnology company, based on their own proprietary
RNA interference (RNAi) technology regulating the expression of disease-causing...